Pharma

Novartis in court bid to block commissioner from releasing inspection information

Drug giant claims disclosing findings will have a ‘chilling effect’ on relationship between regulator and firms, and that it will not benefit the public

Swiss-headquartered Novartis argued that the records relating to inspection reports should be refused in full. Picture: Getty